... to the pages of Key Opinions in Medicine (KOM) KOM is a newsletter service delivered by Wiley-Blackwell to update healthcare professionals on new developments across various therapy areas.

KOM began its life with Dermatology and Hematology, but we are constantly trying to broaden our spectrum and grow. We are looking forward to interaction with our readers so please feel free to send questions and comments to us.

Latest Issues

Insulin deter versus neutral protamine Hagedorn insulin: efficacy and safety

Insulin-replacement therapy is the only effective treatment for type 1 diabetes; it is also used to treat many patients with type 2 diabetes. Additionally, it is one of the forms of intensive diabetes therapy that can delay the development and progression of chronic diabetes-related vascular complications in both type 1 and type 2 diabetes.

Topic: Diabetes and Endocrinology issue: 4/2014

Effect of insulin detemir on hypoglycaemia: evidence in different patient populations

Hypoglycaemia may occur as a corollary of glucose-lowering therapies in patients with diabetes. Restoring glycaemic control is fundamental to the management of both type 1 diabetes and type 2 diabetes and helps to reduce the risk of vascular complications; however, glucose-lowering therapy is also often associated with a concurrent increase in the risk of hypoglycaemia.

Topic: Diabetes and Endocrinology issue: 3/2014

Weight gain with insulin therapy: are there any differences between different basal insulins?

Obesity levels have more than doubled worldwide since 1980 and continue to increase each year. Excess body weight is a known risk factor for the development of type 2 diabetes, which has also reached epidemic status. In 2013 there were 382 million people with diabetes worldwide and this figure is predicted to rise to 592 million people by 2035.

Topic: Diabetes and Endocrinology issue: 2/2014

Is salvage therapy possible in patients with diffuse large B-cell lymphoma (DLBCL) after failure of standard second-line regimens?

The following is an overview of a satellite symposium held on 29 April 2014 during the BSH Annual Scientific Meeting in Birmingham. The symposium was organised and funded by CTI Life Sciences and this report was funded by CTI Life Sciences.

Topic: Haematology issue: 1/2014


Etwa 20.000 Psoriasis-Patienten in Deutschland erhalten heute eine Therapie mit Fumarsäureestern. Ein besonderer Vorteil ist, dass diese Behandlung in vielen klinischen Situationen, z.B. auch bei Nagel- oder Kopfhautbefall anwendbar ist.

Außerdem in dieser Ausgabe: Intervie mit Dr. Philipp und Prof. Mrowietz und Kongresssplitter von der 24. FoBi.

Topic: Dermatology issue: 10/2014


KOM is an international publication that can appear in different languages. We offer our sponsors the option to publish across multiple languages or choose one. Please let us know when you need an issue in another language than the one shown.